BBT Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-10,062
Closed -$436K – 107
2019
Q2
$436K Buy
+10,062
New +$421K 0.51% 69
2014
Q1
– Sell
-20,363
Closed -$624K – 322
2013
Q4
$624K Hold
20,363
– – 0.03% 259
2013
Q3
$585K Sell
20,363
-1,986,384
-99% -$57M 0.03% 266
2013
Q2
$56.2M Hold
2,006,747
– – 2.97% 2

Other funds holding PFE

BBT Capital Management's PFE Position: Q3 2019 in Review

BBT Capital Management sold out of Pfizer (PFE) in Q3 2019, closing a stake of 10,062 shares — an estimated $436K sold.

BBT Capital Management first reported a position in PFE in Q2 2013 and held it in 4 quarters. The position peaked at $56.2M in Q2 2013. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • BBT Capital Management reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • BBT Capital Management sold 10,062 Pfizer shares in Q3 2019, an estimated $436K.
  • BBT Capital Management first reported a position in Pfizer in Q2 2013 and held it in 4 quarters.
  • BBT Capital Management's Pfizer position peaked at $56.2M in Q2 2013.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on BBT Capital Management's 13F filing for Q3 2019.